Pharmaceutical Patent IssuesDIANE Publishing, 2000 - 291 lappuses Witnesses: Michael Kantor, U.S. Trade Rep.; William Brock, former U.S. Trade Rep.; Gerald Mossinghoff, Pharmaceutical Research & Mfrs. of Amer.; Charles Cooper, Shaw, Pittman, Potts & Trowbridge; James Firman, Generic Drug Equity Coalition, & pres., Nat. Council of the Aging; Judith Simpson, United Patients' Assoc. for Pulmonary Hypertension; Robert Gunter, Nat. Pharm. Alliance, & Novo-Pharm; John Klein, Generic Pharm. Ind. Assoc.; Bruce Downey, Barr Labs.; Eran Broshy, Boston Consulting Group; David Beier, Genentech, for the Biotech. Industry Org.; Henry Grabowski, Duke Univ.; Daniel Perry, Alliance for Aging Research; & Dixie Horning, Gray Panthers. |
No grāmatas satura
1.–5. rezultāts no 100.
3. lappuse
... legislation . When Senator DeWine and I offered an amendment on the Senate floor on De- cember 7 , 1995 , calling ... legislative com- promise that provided special rules for generic drugs to give the generic drug indus- try an advantage ...
... legislation . When Senator DeWine and I offered an amendment on the Senate floor on De- cember 7 , 1995 , calling ... legislative com- promise that provided special rules for generic drugs to give the generic drug indus- try an advantage ...
4. lappuse
... legislation and has done a lot of good through the years , but now we need to examine it to see if there is any fine tuning that needs to occur . At that hearing , we will begin to assess how the many changes that have occurred in the ...
... legislation and has done a lot of good through the years , but now we need to examine it to see if there is any fine tuning that needs to occur . At that hearing , we will begin to assess how the many changes that have occurred in the ...
7. lappuse
... legislation , and he brings a real expertise to this issue . I think all of us both on this committee and in the Sen- ate will benefit from these hearings . I want to welcome our colleagues , Senator Faircloth , Senator Chafee , Senator ...
... legislation , and he brings a real expertise to this issue . I think all of us both on this committee and in the Sen- ate will benefit from these hearings . I want to welcome our colleagues , Senator Faircloth , Senator Chafee , Senator ...
8. lappuse
... legislation implementing GATT , Congress dealt with the problem by permitting firms to market their product on the pre - GATT expiration date if they had made a substantial invest- ment or commenced product activity before June 8 , 1995 ...
... legislation implementing GATT , Congress dealt with the problem by permitting firms to market their product on the pre - GATT expiration date if they had made a substantial invest- ment or commenced product activity before June 8 , 1995 ...
9. lappuse
... legislation of Senator Pryor's , and then I go on to praise him . The Chairman . He points out the wicked things that I do , too . [ The prepared statement of Senator Leahy follows : ] Prepared Statement Of Senator Patrick Leahy I have ...
... legislation of Senator Pryor's , and then I go on to praise him . The Chairman . He points out the wicked things that I do , too . [ The prepared statement of Senator Leahy follows : ] Prepared Statement Of Senator Patrick Leahy I have ...
Bieži izmantoti vārdi un frāzes
American ANDA benefits bill biotechnology Bolar brand companies Bristol-Myers Squibb captopril CHAIRMAN Committee Congress consumers cost Delta period district court dollars drug application drug companies drug industry drug manufacturers drug patent Drug Price Competition effective enacted equitable remuneration FDA approval February 13 Federal filing Flolan Food and Drug GATT Glaxo Grabowski granted Hatch-Waxman Act implementing incentives innovation intellectual property issue KANTOR legislation Medicaid ment million MOSSINGHOFF neric paragraph IV certification patent expiration dates patent extension patent holder patent law patent protection patent term extension Patent Term Restoration percent pharma pharmaceutical industry pharmaceutical patents pioneer drug Premarin prescription drugs property rights ranitidine regulatory research and development Round Agreements Act Royce Royce's Senator FEINSTEIN Senator Pryor submitted substantial investment term of patents Term Restoration Act tion transition provisions transition rules U.S. patent U.S. Senate United URAA Uruguay Round Agreements Waxman Waxman-Hatch Amendments Zantac
Populāri fragmenti
183. lappuse - Congressional enactment of the Drug Price Competition and Patent Term Restoration Act of 1984 (PL 98-417).
254. lappuse - ... one of the most essential sticks in the bundle of rights that are commonly characterized as property.
190. lappuse - Subject to the payment of fees under this title, such grant shall be for a term beginning on the date on which the patent issues and ending 20 years from the date on which the application for the patent was filed...
87. lappuse - Except as otherwise provided in this title, whoever without authority makes, uses, offers to sell or sells any patented invention, within the United States or imports into the United States any patented invention during the term of the patent therefor, infringes the patent.
195. lappuse - The Office of Management and Budget advises that it has no objection to this report from the standpoint of the Administration's program.
107. lappuse - Thank you, Mr. Chairman, and thank you to the members of the committee for inviting me to submit testimony regarding the extension of the Voting Rights Act language assistance amendments.
87. lappuse - RNA, hybridoma technology, or other processes involving site specific genetic manipulation techniques) solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use, or sale of drugs or veterinary biological products.
255. lappuse - ... to those who entitle themselves to such grants. The Government of the United States, as well as the citizen, is subject to the Constitution; and when it grants a patent the grantee is entitled to it as a matter' of right, and does not receive it, as was originally supposed to be the case in England, as a matter of grace and favor.
267. lappuse - Upon finding for the claimant the court shall award the claimant damages adequate to compensate for the infringement but in no event less than a reasonable royalty for the use made of the invention by the infringer, together with interest and costs as fixed by the court.
67. lappuse - ... personal" right, whether the "property" in question be a welfare check, a home, or a savings account. In fact, a fundamental interdependence exists between the personal right to liberty and the personal right in property. Neither could have meaning without the other.